Search - tctmd.com

Displaying 61 - 77 of 77

Sort: Relevancy | Date

Presentation TCT 2014

STEMI Transfer Timing Strategies: Have We Maximized the Benefits?

Presenter: Cindy L. Grines, Neal S. Kleiman, Brahmajee K. Nallamothu

September 14, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

Presentation Fellows 2014

State-of-the-Art in ACS and STEMI: Risk Stratification, Reperfusion Strategies, and Guidelines

Presenter: Gregg Stone

April 12, 2014

Presentation Fellows 2014

ACS Case 1

Presenter: Sripal Bangalore

April 12, 2014

Presentation Fellows 2013

Case 1(6)

Presenter: Manish Parikh

April 16, 2013

Presentation Fellows 2013

Treatment of Non-ST-Elevation ACS: Risk Stratification and Conservative vs. Invasive Management

Presenter: Sripal Bangalore

April 16, 2013

Presentation Fellows 2013

Reperfusion Therapy in STEMI: Reperfusion Strategies and Guidelines

Presenter: Manish Parikh

April 16, 2013

Presentation Fellows 2013

Case 1(5)

Presenter: Sripal Bangalore

April 16, 2013

News Daily News

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Caitlin E. Cox

December 19, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Presentation Fellows 2012

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Presenter: Michael Ezekowitz

April 22, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

Presentation Fellows 2012

Bivalirudin in ACS and PCI

Presenter: Gregg Stone

April 22, 2012

Presentation Fellows 2012

Reperfusion Therapy in STEMI: Guideline, Strategies, Pharmacology, and Stent Selection

Presenter: Gregg Stone

April 21, 2012

Presentation Fellows 2012

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

Presenter: George Dangas

April 21, 2012

CME

Advertisement

STEMI Transfer Timing Strategies: Have We Maximized the Benefits?

Are GP IIb/IIIa Inhibitors Still Useful?

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

State-of-the-Art in ACS and STEMI: Risk Stratification, Reperfusion Strategies, and Guidelines

ACS Case 1

Case 1(6)

Treatment of Non-ST-Elevation ACS: Risk Stratification and Conservative vs. Invasive Management

Reperfusion Therapy in STEMI: Reperfusion Strategies and Guidelines

Case 1(5)

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Oral Antiplatelet Agents in PCI and ACS

Bivalirudin in ACS and PCI

Reperfusion Therapy in STEMI: Guideline, Strategies, Pharmacology, and Stent Selection

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content